BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4405704)

  • 1. Hybrid resistance to parental DBA-2 grafts: independence from the H-2 locus. I. Studies with normal hematopoietic cells.
    Cudkowicz G; Rossi GB
    J Natl Cancer Inst; 1972 Jan; 48(1):131-9. PubMed ID: 4405704
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid resistance to parental DBA-2 grafts: independence from the H-2 locus. II. Studies with Friend virus-induced leukemia cells.
    Cudkowicz G; Rossi GB; Haddad JR; Friend C
    J Natl Cancer Inst; 1972 Apr; 48(4):997-1003. PubMed ID: 4554118
    [No Abstract]   [Full Text] [Related]  

  • 3. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.
    Cudkowicz G; Bennett M
    J Exp Med; 1971 Dec; 134(6):1513-28. PubMed ID: 4942407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to parental, allogeneic and xenogeneic hemopoietic grafts in irradiated mice.
    Lotzová E
    Exp Hematol; 1977 May; 5(3):215-35. PubMed ID: 326573
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance of irradiated F 1 hybrid and allogeneic mice to bone marrow grafts of NZB donors.
    Lotzová E; Cudkowicz G
    J Immunol; 1973 Mar; 110(3):791-800. PubMed ID: 4569800
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of marrow allograft rejection with radioactive strontium: evidence for marrow-dependent effector cells.
    Bennett M
    J Immunol; 1973 Feb; 110(2):510-6. PubMed ID: 4405320
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of abrogating hybrid resistance on the survival of radiation chimeras].
    Chertkov IL; Gurevich OA
    Biull Eksp Biol Med; 1977 Jan; 83(1):42-4. PubMed ID: 15680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemopoietic cell-defined components of the major histocompatibility complex of mice: identification of responsive and unresponsive recipients for bone marrow transplants.
    Cudkowicz G; Lotzová E
    Transplant Proc; 1973 Dec; 5(4):1399-405. PubMed ID: 4130054
    [No Abstract]   [Full Text] [Related]  

  • 9. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice.
    Cudkowicz G; Bennett M
    J Exp Med; 1971 Jul; 134(1):83-102. PubMed ID: 4397663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid resistance to parental WB-Re bone marrow grafts. Association with genetic markers of linkage group IX.
    Lotzová E; Cudkowicz G
    Transplantation; 1972 Mar; 13(3):256-64. PubMed ID: 4553727
    [No Abstract]   [Full Text] [Related]  

  • 11. An in vitro model of hybrid resistance to bone marrow grafts.
    Shearer GM; Waksal H; Cudkowicz G
    Transplant Proc; 1976 Sep; 8(3):469-75. PubMed ID: 10653
    [No Abstract]   [Full Text] [Related]  

  • 12. Conditioning recipients of hemopoietic cells with antilymphocytic serum (ALS) and partial-body irradiation.
    Kolb H; Thierfelder S; Baumann P; Balk O
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):810-4. PubMed ID: 4399647
    [No Abstract]   [Full Text] [Related]  

  • 13. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weakening of genetic resistance. II. The effect of injection of the macrophage toxic agents silica and carragheenan and the cytostatic drugs cyclophosphamide, busulphan and vinblastin.
    Buurman WA; van Bruggen I
    Exp Hematol; 1976 Nov; 4(6):382-92. PubMed ID: 186293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of macrophages in genetic resistance to bone marrow grafts. Studies with two specific antimacrophage agents, carrageenan and silica.
    Lotzova E; Gallagher MT; Trentin JJ
    Biomedicine; 1975 Sep; 22(5):387-92. PubMed ID: 177111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of bone marrow transplantation in irradiated mice: classification of mouse strains according to their responsiveness to bone marrow allografts and xenografts.
    Lotzová E; Dicke KA; Trentin JJ; Gallagher MT
    Transplant Proc; 1977 Mar; 9(1):289-92. PubMed ID: 325768
    [No Abstract]   [Full Text] [Related]  

  • 18. [Origin of CFUS in extramedullary bone marrow transplants].
    Starostin VI
    Dokl Akad Nauk SSSR; 1980; 251(6):1511-2. PubMed ID: 6104570
    [No Abstract]   [Full Text] [Related]  

  • 19. Maternal modification of antigen recognition in the ova-transfer substrain R3eB.
    Uphoff DE
    J Natl Cancer Inst; 1972 Feb; 48(2):517-22. PubMed ID: 4405705
    [No Abstract]   [Full Text] [Related]  

  • 20. Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the anti-macrophage agent seakem carrageenan.
    Cudkowicz G; Yung YP
    J Immunol; 1977 Aug; 119(2):483-7. PubMed ID: 196023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.